ESHELMAN VENTURES
Eshelman Ventures, based in New Castle, provides investment to private healthcare companies.
ESHELMAN VENTURES
Industry:
Financial Services Health Care Venture Capital
Status:
Active
Contact:
(910) 558-6885
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Font Awesome
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-31 | Sapience Therapeutics | Eshelman Ventures investment in Series B - Sapience Therapeutics | 41 M USD |
| 2022-03-31 | Incyclix Bio | Eshelman Ventures investment in Series B - Incyclix Bio | 30 M USD |
| 2022-01-03 | Aravive Biologics | Eshelman Ventures investment in Post-IPO Equity - Aravive Biologics | 10 M USD |
| 2020-08-06 | Incyclix Bio | Eshelman Ventures investment in Venture Round - Incyclix Bio | 6 M USD |
| 2019-12-26 | Liquidia Technologies | Eshelman Ventures investment in Post-IPO Equity - Liquidia Technologies | 22.4 M USD |
| 2019-12-19 | Kinnate Biopharma | Eshelman Ventures investment in Series B - Kinnate Biopharma | 74.5 M USD |
| 2019-07-24 | Aruna Biomedical | Eshelman Ventures investment in Venture Round - Aruna Biomedical | 13 M USD |
| 2018-04-01 | Kinnate Biopharma | Eshelman Ventures investment in Series A - Kinnate Biopharma | 22 M USD |
| 2016-07-12 | Sapience Therapeutics | Eshelman Ventures investment in Series A - Sapience Therapeutics | 22.5 M USD |
| 2016-05-11 | G1 Therapeutics | Eshelman Ventures investment in Series C - G1 Therapeutics | 47 M USD |